Cipher Pharmaceuticals Inc
PHE
Company Profile
Business description
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
Contact
5750 Explorer Drive
Suite 404
MississaugaONL4W 0A9
CANT: +1 905 602-5840
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
43
Stocks News & Analysis
stocks
Earnings margins to improve for mining specialist
Premium products drive margins yet shares fully valued.
stocks
Nvidia: Hugging Face acquisition both a wise offensive and defensive move
We think this improves Nvidia’s position within the open-source community.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,200.60 | 12.10 | -0.13% |
| CAC 40 | 8,287.65 | 8.88 | 0.11% |
| DAX 40 | 25,971.57 | 74.83 | -0.29% |
| Dow JONES (US) | 53,414.25 | 271.86 | -0.51% |
| FTSE 100 | 10,846.29 | 15.20 | 0.14% |
| HKSE | 25,413.12 | 237.75 | -0.93% |
| NASDAQ | 26,506.99 | 77.07 | -0.29% |
| Nikkei 225 | 66,399.84 | 1,378.90 | 2.12% |
| NZX 50 Index | 13,942.83 | 31.35 | -0.22% |
| S&P 500 | 7,718.60 | 29.11 | -0.38% |
| S&P/ASX 200 | 9,010.90 | 12.50 | -0.14% |
| SSE Composite Index | 3,932.70 | 2.58 | 0.07% |